Uveitis following intraocular surgery

Ophthalmology Clinics of North America

Volumn 15, Issue 3, 2002, Pages 357-364

  Berrocal, Audina M ^a   Davis, Janet L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

CATARACT EXTRACTION; ENDOPHTHALMITIS; EYE INFLAMMATION; EYE SURGERY; HUMAN; LENS IMPLANTATION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; REINFECTION; REVIEW; SCLERITIS; SYMPATHETIC OPHTHALMIA; UVEITIS;

EYE DISEASES; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; UVEITIS;

EID: 0036710475     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00032-9     Document Type: Review

References (98)

1. Wenzel M, Dahlke C, Tahmaz E, et al. Value of corticosteroids in after-care of patients after cataract extraction and lens implantation. Klin Monatsbl Augenheilkd 1992;200:262-6.
2. Solomon KD, Cheetham JK, DeGryse R, et al. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 2001;108:331-7.
3. Heier J, Cheetham JK, Degryse R, et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial. Am J Ophthalmol 1999;127:253-9.
4. Solomon KD, Vroman DT, Barker D, et al, Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction: Prospective randomized double-masked study. J Cataract Refract Surg 2001;27:1232-7.
5. Reddy MS, Suneetha N, Thomas RK, et al. Topical diclofenac sodium for treatment of postoperative inflammation in cataract surgery. Indian J Ophthalmol 2000;48:223-6.
6. Missotten L, Richard C, Trinquand C. Topical 0.1% indomethacin solution versus topical 0.1% dexamethasone solution in the prevention of inflammation after cataract surgery. The Study Group. Ophthalmologica 2001;215:43-50.
7. Guzey M, Karadede S, Dogan Z, et al. Ketorolactobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with sclera tunnel incision. Ophthalmic Surg Lasers 2000;31:451-6.
8. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999;25:699-704.
9. Herbort CP, Jauch A, Othenin-Girard P, et al. Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand 2000;78:421-4.
10. Flach AJ, Dolan BJ, Donahue ME, et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 1998;105:1775-9.
11. Diestelhorst M, Aspacher F, Konen W, et al. Effect of dexamethasone 0.1% and prednisolone acetate 1% eye drops on the blood-aqueous barrier after cataract surgery: A controlled randomized fluorophotometric study. Graefes Arch Clin Exp Ophthalmol 1992;230:451-3.
12. Weijtens O, van der Sluijs FA, Schoemaker RC, et al. Peribulbar corticosteroid injection: Vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol 1997;123:358-63.
13. Weijtens O, Feron EJ, Schoemaker RC, et al. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 1999;128:192-7.
14. Weijtens O, Schoemaker RC, Cohen AF, et al. Dexamethasone concentration in vitreous and serum after oral administration. Am J Ophthalmol 1998;125:673-9.
15. Fukushima H, Kato S, Kaiva T, et al. Effect of subconjunctival steroid injection on intraocular inflammation and blood glucose level after cataract surgery in diabetic patients. J Cataract Refract Surg 2001;27:1386-91.
16. Schmitt K, Hessemer V. Is subconjunctival steroid administration in addition to local therapy after cataract operations necessary? A laser tyndallometric study. Ophthalmologe 1995;92:303-6.
17. Foster RE, Lowder CY, Meisler DM, et al. Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology 1992;99:1234-41.
18. Estafanous MF, Lowder CY, Meisler DM, et al. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol 2001;131:620-5.
19. BenEzra D, Cohen E. Cataract surgery in children with chronic uveitis. Ophthalmology 2000;107:1255-60.
20. Irvine SR. A newly defined syndrome following cataract surgery, interpreted according to recent concepts of the structure of the vitreous. Am J Ophthalmol 1953;36:599-619.
21. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 3rd Edition. St. Louis: CV Mosby; 1987. p. 333-453.
22. Yanoff M, Fine BS. Ocular Pathology: A Text and Atlas. 3rd Edition. Philadelphia: JB Lippincott: 1989. p. 102-62.
23. Gass JDM, Norton EWD. Cystoid macular edema and papilledema following cataract extraction: A fluorescein funduscopic and angiographic study. Arch Ophthalmol 1966;76:646-62.
24. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 1998;96:557-634.
25. Rosetti L, Chaudhuri J, Dickersin K, et al. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery: The results of a meta-analysis. Ophthalmology 1998;105:397-405.
26. Rho D. Acetazolamide treatment of CME in patients with uveitis. Ophthalmology 1996;103:1717-8.
27. Flach A. Acetazolamide treatment of CME in patients with uveitis. Ophthalmology 1996;103:1715-7.
28. Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol 1999;97:297-309.
29. Yoshikawa K, Kotake S, Ichiishi A, et al. Posterior sub-tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995;39:71-6.
30. Guex-Crosier Y, Othenin-Girard P, Herbort CP. Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema. Klin Monatsbl Augenheilkd 1992;200:367-73.
31. Lardenoye CW, van Schooneveld MJ, Frits Treffers W, et al. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol 1998;82:1013-6.
32. Fung WE. Vitrectomy for chronic aphakic cystoid macular edema: Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 1985;92:1102-11.
33. Harbour JW, Smiddy WE, Rubsamen PE, et al. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 1995;120:302-7.
34. Meltzer DW. Sterile hypopyon following intraocular lens surgery. Arch Ophthalmol 1980;98:100-4.
35. Stark WJ, Rosenblum P, Maumenee AE, et al. Postoperative inflammatory reactions to intraocular lenses sterilized with ethylene-oxide. Ophthalmology 1980;87:385-9.
36. Scheiffarth OF, Ludwig K, von Meyer L. Determination of ethylene oxide in gas-sterilized lenses: A possible cause of inflammatory reactions following intraocular lens implantation? Fortschritte der Ophthalmologie 1984;81:140-2.
37. Shepard DD. The dangers of metal loop intraocular lenses. Ophthalmic Surg 1977;8:93-5.
38. Hagan III JC. A clinical review of the IOLAB Azar model 91Z flexible anterior chamber intraocular lens. Ophthalmic Surg Lasers 1987;18:258-61.
39. Girard LJ, Madero R, Monasterio R. Complications of the Simcoe flexible loop phacoprosthesis in the anterior chamber. Ophthalmic Surg Lasers 1983;14:332-5.
40. Ellingson FT. The uveitis-glaucoma-hyphema syndrome associated with the Mark VIII anterior chamber lens implant. J Am Intraocul Implant Soc 1978;4(2):50-3.
41. Choyce DP. Complications of the AC implants of the early 1950's and the UGH or Ellingson syndrome of the late 1970's. J Am Intraocul Implant Soc 1978;4:22-9.
42. Lee DA, Price Jr. FW, Whitson WE. Intraocular complications associated with the Dubroff anterior chamber lens. J Cataract Refract Surg 1994;20:421-5.
43. Aonuma H, Matsushita H, Nakajima K, Watanabe I, et al. Uveitis-glaucoma-hyphema syndrome after posterior chamber intraocular lens implantation. Jpn J Ophthalmol 1997;41:98-100.
44. Masket S. Pseudophakic posterior iris chafing syndrome. J Cataract Refract Surg 1986;12:252-6.
45. Van Liefferinge T, Van Oye R, Kestelyn P. Uveitisglaucoma-hyphema syndrome: A late complication of posterior chamber lenses. Bull Soc Belge Ophtalmol 1994;252:61-6.
46. Percival SP, Das SK. UGH syndrome after posterior chamber lens implantation. J Am Intraocul Implant Soc 1983;19:200-1.
47. Assoa EI, Blumenthal M. Recurrent hyphema associated with IOL loop displacement treated with argon laser photocoagulation. Ophthalmic Surg Lasers 1993;24:343-5.
48. Geisse LJ. Nd: YAG laser treatment for recurrent hyphemas in pseudophakia. Am J Ophthalmol 1991;111:513.
49. Magargal LE, Goldberg RE, Uram M, et al. Recurrent microhyphema in the pseudophakic eye. Ophthalmology 1983;90:1231-4.
50. Hagan III JC. Complications while removing the IO-LAB 91Z lens for the UGH-UGH+ syndrome. J Am Intraocul Implant Soc 1984;10:209-13.
51. Balent A, Civerchia L, Mohamadi P. Intraocular lens implant exchange and resolution of cystoid macular edema. J Cataract Refract Surg 1986;12:184-5.
52. Doren GS, Stern GA, Driebe WT. Indications for and results of intraocular lens explanation. J Cataract Refract Surg 1992;18:79-85.
53. Pande M, Dabbs TR. Incidence of lens matter dislocation during phacoemulsification. J Cataract Refract Surg 1996;22:737-42.
54. Stilma JS, van der Sluijs FA, van Meurs JC, et al. Occurrence of retained lens fragments after phacoemulsification in The Netherlands. J Cataract Refract Surg 1997;23:1177-82.
55. Vilar NF, Flynn HW, Smiddy WE, et al. Removal of retained lens fragments after phacoemulsification reverses secondary glaucoma and restores visual acuity. Ophthalmology 1997;104:787-92.
56. Marak GE. Phacoanaphylactic endophthalmitis. Surv Ophthalmol 1992;36:325.
57. Marak GE, Rao NA. Lens protein binding lymphocytes. Ophthalmic Res 1983;15:6.
58. Thach AB, Marak GE, McLean IW, Green WR. Phacoanaphylactic endophthalmitis: A clinicopathologic review. Int Ophthalmol 1991;15:271-9.
59. Marak GE, Font RL, Rao NA. Abrogation of tolerance to lens protein 1. Effects of lipopolysaccaride. Ophthalmic Res 1979;11:92.
60. Cousins SW, Mackiw E. Lens-associated uveitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection and Immunity. St. Louis: Mosby; 1996. p. 507-28.
61. Albert DM, Diaz-Rohena R. A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol 1989;34:1-14.
62. Chan CC, Mochizuki M. Sympathetic ophthalmia: An autoimmune ocular inflammatory disease. Springer Semin Immunopathol 1999;21:125-34.
63. Chan CC, Roberge RG, Whitcup SM, et al. Thirty-two cases of sympathetic ophthalmia: A retrospective study at the National Eye Institute, Bethesda, MD, from 1982 to 1992 [erratum appears in Arch Ophthalmol 1995;113:1507. Arch Ophthalmol 1995;113:597-600.
64. Lyons C, Tuft S, Lightman S. Sympathetic ophthalmia from inadvertent ocular perforation during conventional retinal detachment surgery. Br J Ophthalmol 1997;81:612.
65. Lam S, Tessler HH, Lam BL, et al. High incidence of sympathetic ophthalmia after contact and noncontact neodymium: YAG cyclotherapy. Ophthalmology 1992;99:1818-22.
66. Tamai M, Obara J, Mizuno K, et al. Sympathetic ophthalmia: Induced by vitrectomy not by trauma. Jpn J Ophthalmol 1984;28:75-9.
67. Wang WJ. Clinical and histopathological report of sympathetic ophthalmia after retinal detachment surgery. Br J Ophthalmol 1983;67:150-2.
68. Brown SV, Higginbotham E, Tessler H. Sympathetic ophthalmia following Nd: YAG cyclotherapy. Ophthamic Surg 1990;21:736.
69. Edward DP, Brown SV, Higginbotham E, et al. Sympathetic ophthalmia following neodymium: YAG cyclotherapy. Ophthalmic Surg 1989;20:544-6.
70. Marak Jr. GE. Sympathetic uveitis. In: Yanoff M, Duker JS, editors. Ophthalmology. London: Mosby International; 1999. p. 10.20.1.
71. Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol 2000;84:259-63.
72. Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia: A clinicopathologic review of 105 cases (1913-1978). Ophthalmology 1980;87:109.
73. Zaharia MA, Lamarche J, Laurin M. Sympathetic uveitis 66 years after injury. Can J Ophthalmol 1984;19:240.
74. Ramadan A, Nussenblatt RB. Visual prognosis and sympathetic ophthalmia. Curr Opin Ophthalmol 1996;7:39.
75. Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1990;30:279.
76. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969;81:481-93.
77. Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1997;123:1-16.
78. Bosch-Driessen LH, Plaisier MB, Stilma JS, et al. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology 2002;109:41-5.
79. O'Connor GR. Factors related to the initiation and recurrence of uveitis. 15th Edward Jackson Memorial Lecture. Am J Ophthalmol 1983;96:577-99.
80. Wilder HC. Toxoplasma chorioretinitis in adults. Arch Ophthalmol 1952;48:127-8.
81. Kattan HM, Flynn HW, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Ophthalmology 1991;98:227-38.
82. Javitt JC, Vitale S, Canner JK, Street DA, Krakauer H, McBean AM, et al. National outcome of cataract extraction. Arch Ophthalmol 1991;109:1085-9.
83. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study: A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-96.
84. Mandelbaum S, Forster RK, Gelender H, Culbertson W. Late onset endophthalmitis associated with filtering blebs. Ophthalmology 1985;92:964-72.
85. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053-60.
86. Higginbotham EJ, Stevens RK, Musch DC. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103:650-6.
87. Han DP, Wisniewski SR, Kelsey SF, et al. Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 1999;19:98-102.
88. Driebe Jr. WT, Mandelbaum S, Forster RK, Schwartz LK, Culbertson WW. Pseudophakic endophthalmitis: Diagnosis and management. Ophthalmology 1986;93:442-8.
89. Donahave S, Kowalski R, Jewart B. Vitreous cultures in suspected endophthalmitis: Biopsy or vitrectomy. Ophthalmology 1993;100:452-9.
90. Winward KE, Pflugfelder SC, Flynn HW, et al. Postoperative Propionibacterium endophthalmitis: Treatment strategies and long-term results. Ophthalmology 1993;100:447-51.
91. Zambrano W, Flynn HW, Pflugfelder SC, et al. Management options for Propionibacterium acnes endophthalmitis. Ophthalmology 1989;96:1100-5.
92. Clark WL, Kaiser PK, Flynn Jr. HW, et al. Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999;106:1665-70.
93. Aldave AJ, Stein JD, Deramo VA, et al. Treatment Strategies for postoperative propionibacterium endophthalmitis. Ophthalmology 1999;106:2395-401.
94. Theodore FH. Etiology and diagnosis of fungal postoperative endophthalmitis. Ophthalmology 1978;85:327-40.
95. Hanssens M. A peculiar case of necrotizing sclerokeratitis with Pseudomonas infection. Bull Soc Belge Ophtalmol 1995;259:45-52.
96. Gross SA, von Noorden GK, Jones DB. Necrotizing scleritis and transient myopia following strabismus surgery. Ophthalmic Surg Lasers 1993;24:839-41.
97. Jones RR, Maguire LJ. Corneal complications after cataract surgery in patients with rheumatoid arthritis. Cornea 1992;11:148-50.
98. Lyne AJ, Lloyd-Jones D. Necrotizing scleritis after ocular surgery. Trans Ophthalmol Soc U K 1979;99:146-9.